United States · FDA National Drug Code directory
carisoprodol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16571-781_cca322f3-3e46-4de8-9e37-8fe9039d40c7
- Product NDC
- 16571-781
- Form
- TABLET
- Composition / generic term
- carisoprodol
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090806
- Source listing expiry
- 20261231
Source-listed ingredients
- CARISOPRODOL — 350 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (16571-781-01) · 16571-781-01
- 1000 TABLET in 1 BOTTLE (16571-781-10) · 16571-781-10
- 500 TABLET in 1 BOTTLE (16571-781-50) · 16571-781-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →